Share of clinical development medicines dedicated to non-communicable diseases
STO-REC-STAT01M2KJT2 National
75%
Global · 2025
Share of clinical development medicines dedicated to non-communicable diseases worldwide stood at 75% in 2025 (IFPMA).
- Publisher
- IFPMA
- Authority tier
- T2 National
- Locator
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
And in 2025, over 12,900 medicines were in clinical development worldwide, with three-quarters dedicated to non-communicable diseases (NCDs).
Verbatim extraction verified: The figure 75% is directly attested in the quoted passage (Enabling innovation: The R&D ecosystem for medicines and vaccines).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- IFPMA. (2025). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1
- MLA
- IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025, https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1.
- Chicago
- IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2025. https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1.
- BibTeX
- @misc{ifpma2025sharebjmgf1, author = {{IFPMA}}, title = {Enabling innovation: The R\&D ecosystem for medicines and vaccines}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1}, note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- IFPMA · homepage ↗
- Authority tier
- Tier 2 · National Official
- Report
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Type
- Press release
- Published
- —
- Locator
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 15 September 2026
- Last revision
- 15 September 2026
- Archival URI
- /stat/stat_01M2KJ7XCG3Y4BJ2059JBJMGF1